Total Non-Current Liabilities

$46.66B

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$46.66Bperiod endingJun 30, 2026

BMY Quarterly Total Non-Current Liabilities ($630.00M → $46.66B)

Quarterly total non-current liabilities

High-resolution chart · PNG

BMY total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Total Non-Current Liabilities — Quarterly (USD)
Period ending	Total Non-Current Liabilities (USD)
Jun 30, 2001	2,676,000,000
Mar 31, 2001	2,724,000,000
Dec 31, 2000	2,766,000,000
Sep 30, 2000	2,752,000,000
Jun 30, 2000	2,783,000,000
Mar 31, 2000	2,910,000,000
Dec 31, 1999	2,932,000,000
Sep 30, 1999	2,770,000,000
Jun 30, 1999	2,787,000,000
Mar 31, 1999	2,917,000,000
Dec 31, 1998	2,905,000,000
Sep 30, 1998	2,733,000,000
Jun 30, 1998	2,748,000,000
Mar 31, 1998	2,865,000,000
Dec 31, 1997	2,726,000,000
Sep 30, 1997	3,083,000,000
Jun 30, 1997	2,842,000,000
Mar 31, 1997	2,958,000,000
Dec 31, 1996	3,065,000,000
Sep 30, 1996	2,841,000,000
Jun 30, 1996	2,919,000,000
Mar 31, 1996	3,128,000,000
Dec 31, 1995	3,301,000,000
Sep 30, 1995	2,854,000,000
Jun 30, 1995	2,969,000,000
Mar 31, 1995	2,906,000,000
Dec 31, 1994	2,932,000,000
Sep 30, 1994	2,956,000,000
Jun 30, 1994	3,071,000,000
Mar 31, 1994	3,126,000,000
Dec 31, 1993	3,096,000,000
Sep 30, 1993	1,798,000,000
Jun 30, 1993	1,800,000,000
Mar 31, 1993	1,466,000,000
Dec 31, 1992	1,484,000,000
Sep 30, 1992	842,000,000
Jun 30, 1992	776,000,000
Mar 31, 1992	871,000,000
Dec 31, 1991	869,000,000
Sep 30, 1991	892,000,000
Jun 30, 1991	886,000,000
Mar 31, 1991	939,000,000
Dec 31, 1990	976,000,000
Sep 30, 1990	983,000,000
Jun 30, 1990	958,000,000
Mar 31, 1990	761,000,000
Dec 31, 1989	754,000,000
Dec 31, 1988	712,000,000
Dec 31, 1987	630,000,000